The Funding Most Deep Tech Founders Miss
12 Sept 2026 · 0 min
0:15
In this brief segment, the speaker (identified as Speaker A) argues that non‑dilutive financing is an especially effective way for early‑stage healthcare and biotech startups to secure capital. He positions it as a preferred route before founders engage with traditional equity investors—exemplified by the mention of “Vic”—allowing companies to obtain needed resources without giving up ownership early on.
